| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C17H14F3N3O2S
|
|---|
| Exact mass |
381.0759
|
|---|
| Mol weight |
381.3722
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX33 Celecoxib
D00567 Celecoxib (JP18/USP/INN) <JP/US>
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AH Coxibs
M01AH01 Celecoxib
D00567 Celecoxib (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Analgesics
Nonsteroidal Anti-inflammatory Drugs
Celecoxib
D00567 Celecoxib (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
114 Antipyretics and analgesics, anti-inflammatory agents
1149 Others
D00567 Celecoxib (JP18/USP/INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01922 Selective COX2 inhibitor
DG01907 Anti-inflammatory drug, coxibs
D00567 Celecoxib
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
D00567 Celecoxib
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
D00567 Celecoxib
Drug classes [BR:br08332]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
D00567 Celecoxib
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS2 (COX2)
D00567 Celecoxib (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00567 Celecoxib
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00567
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00567
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D00567
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 26
1 C8y C 23.9550 -17.9615
2 C1d C 25.3545 -17.9615
3 N5x N 23.0687 -16.8419
4 N4y N 21.7625 -17.2618
5 C8y C 21.7625 -18.6613
6 C8x C 23.0687 -19.0811
7 X F 25.3545 -19.3610
8 X F 26.7540 -17.9615
9 X F 25.3545 -16.5620
10 C8y C 18.1237 -15.1625
11 C8x C 18.1237 -16.5620
12 C8x C 19.3366 -17.2618
13 C8y C 20.5496 -16.5620
14 C8x C 20.5496 -15.1625
15 C8x C 19.3366 -14.4628
16 C8x C 18.1237 -19.3610
17 C8y C 18.1237 -20.7606
18 C8x C 19.3366 -21.4603
19 C8x C 20.5496 -20.7606
20 C8y C 20.5496 -19.3610
21 C8x C 19.3366 -18.6613
22 C1a C 16.9109 -21.4603
23 S4a S 16.9109 -14.4628
24 O3c O 17.6106 -13.2498
25 O3c O 16.2111 -15.6756
26 N1a N 15.6979 -13.7630
BOND 28
1 1 2 1
2 1 3 2
3 3 4 1
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 2 8 1
9 2 9 1
10 10 11 2
11 11 12 1
12 12 13 2
13 13 14 1
14 14 15 2
15 10 15 1
16 13 4 1
17 16 17 2
18 17 18 1
19 18 19 2
20 19 20 1
21 20 21 2
22 16 21 1
23 20 5 1
24 17 22 1
25 10 23 1
26 23 24 2
27 23 25 2
28 23 26 1
|
|---|
